Janssen

• A01 - Preparados estomatológicos
• BACTIDOL oromucosal solution 0.1%
• DAKTARIN oromucosal gel 2%
• A03 - Agentes contra padecimientos funcionales del estómago e intestino
• MOTILIUM oral suspension 1 mg/ml
• MOTILIUM tablet 10 mg
• A06 - Agentes contra el estreñimiento
• RESOLOR film-coated tablet 1 mg
• RESOLOR film-coated tablet 2 mg
• B03 - Preparados antianémicos
• EPREX powder for solution for injection 40 000 IU/ml
• EPREX PREFILLED SYRINGE solution for injection 10 000 IU/ml
• EPREX PREFILLED SYRINGE solution for injection 2 000 IU/0.5 ml
• EPREX PREFILLED SYRINGE solution for injection 4 000 IU/0.4 ml
• C05 - Vasoprotectores
• ANUSOL rectal ointment
• ANUSOL suppository
• D01 - Antifúngicos para uso dermatológico
• DAKTACORT cream 2%+1%
• DAKTARIN cream 2%
• DAKTARIN cutaneous powder 2%
• DAKTARIN TINCTURE cutaneous liquid 2%
• NIZORAL cream 2%
• D02 - Emolientes y protectores
• JOHNSONS BABY DIAPER RASH cream
• D08 - Antisépticos y desinfectantes
• MICROSHIELD cutaneous solution 2%
• MICROSHIELD cutaneous solution 4%
• SAVLON cream 0.5%
• D10 - Preparados contra el acné
• RENOVA cream 0.05%
• RETIN A cream 0.05%
• RETIN A cream 0.1%
• RETIN A gel 0.01%
• D11 - Otros preparados dermatológicos
• PROTOPIC ointment 0.03%
• PROTOPIC ointment 0.1%
• REGAINE cutaneous solution 2%
• REGAINE cutaneous solution 5%
• G01 - Antiinfecciosos y antisépticos ginecológicos
• GYNO PEVARYL DEPOT pessary 150 mg
• GYNO PEVARYL pessary 150 mg
• G03 - Hormonas sexuales y moduladores del sistema genital
• EVRA transdermal patch 6 mg+600 µg
• G04 - Urológicos
• LYRINEL prolonged-release tablet 5 mg
• J01 - Antibacterianos para uso sistémico
• DORIBAX powder for solution for infusion 500 mg
• J02 - Antimicóticos de uso sistémico
• NIZORAL tablet 200 mg
• SPORANOX capsule, hard 100 mg
• SPORANOX oral solution 10 mg/ml
• J05 - Antivirales de uso sistémico
• EDURANT film-coated tablet 25 mg
• INTELENCE tablet 100 mg
• PREZISTA film-coated tablet 300 mg
• J07 - Vacunas
• DUKORAL effervescent granules
• L01 - Antineoplásicos
• CAELYX concentrate for solution for infusion 20 mg/10 ml
• DACOGEN powder for solution for infusion 50 mg
• IMBRUVICA capsule, hard 140 mg
• VELCADE powder for solution for injection 3.5 mg
• YONDELIS powder for solution for infusion 1 mg
• L02 - Terapia endocrina
• ZYTIGA tablet 250 mg
• L04 - Inmunosupresores
• ORTHOCLONE OKT3 solution for injection 5 mg/5 ml
• REMICADE powder for solution for infusion 100 mg
• SIMPONI solution for injection 50 mg/0.5 ml
• STELARA PREFILLED SYRINGE solution for injection 45 mg/0.5 ml
• N01 - Anestésicos
• FENTANYL JOHNSON solution for injection 100 µg/2 ml
• RAPIFEN solution for injection 1 mg/2 ml
• SUFENTA solution for injection 50 µg/10 ml
• N02 - Analgésicos
• DUROGESIC transdermal patch 12 µg/h
• DUROGESIC transdermal patch 25 µg/h
• DUROGESIC transdermal patch 50 µg/h
• TYLENOL ER prolonged-release tablet 650 mg
• ULTRACET film-coated tablet 37.5 mg+325 mg
• N03 - Antiepilépticos
• TOPAMAX SPRINKLE capsule, hard 15 mg
• TOPAMAX SPRINKLE capsule, hard 25 mg
• TOPAMAX tablet 100 mg
• TOPAMAX tablet 25 mg
• TOPAMAX tablet 50 mg
• N05 - Psicolépticos
• INVEGA prolonged-release tablet 12 mg
• INVEGA prolonged-release tablet 3 mg
• INVEGA prolonged-release tablet 6 mg
• INVEGA prolonged-release tablet 9 mg
• INVEGA SUSTENNA PROLONGED RELEASE suspension for injection 100 mg
• INVEGA SUSTENNA PROLONGED RELEASE suspension for injection 150 mg
• INVEGA SUSTENNA PROLONGED RELEASE suspension for injection 25 mg
• INVEGA SUSTENNA PROLONGED RELEASE suspension for injection 50 mg
• INVEGA SUSTENNA PROLONGED RELEASE suspension for injection 75 mg
• RISPERDAL CONSTA LONG ACTING powder and solvent for suspension for injection 25 mg
• RISPERDAL CONSTA LONG ACTING powder and solvent for suspension for injection 37.5 mg
• RISPERDAL CONSTA LONG ACTING powder and solvent for suspension for injection 50 mg
• RISPERDAL film-coated tablet 1 mg
• RISPERDAL film-coated tablet 2 mg
• RISPERDAL film-coated tablet 3 mg
• RISPERDAL oral solution 1 mg/ml
• N06 - Psicoanalépticos
• CONCERTA prolonged-release tablet 18 mg
• CONCERTA prolonged-release tablet 27 mg
• CONCERTA prolonged-release tablet 36 mg
• REMINYL prolonged-release capsule, hard 16 mg
• REMINYL prolonged-release capsule, hard 24 mg
• REMINYL prolonged-release capsule, hard 8 mg
• N07 - Otros fármacos activos sobre el sistema nervioso
• DRAMAMINE JUNIOR syrup 12.5 mg/5 ml
• DRAMAMINE tablet 50 mg
• SIBELIUM capsule, hard 5 mg
• STUGERON tablet 25 mg
• P02 - Antihelmínticos
• VERMOX chewable tablet 500 mg
• VERMOX oral suspension 500 mg/10 ml
• VERMOX tablet 500 mg
• R06 - Antihistamínicos para uso sistémico
• BENADRYL syrup 2.5 mg/5 ml+25 mg/5 ml
• S01 - Oftalmológicos
• VISINE eye drops, solution 0.05%